# Anticoagulation Alone Versus Anticoagulation and Aspirin Following Transcatheter Aortic Valve Interventions (1:1)

> **NCT02735902** · PHASE4 · COMPLETED · sponsor: **Centre Hospitalier Universitaire de Nīmes** · enrollment: 170 (actual)

## Conditions studied

- Transcatheter Aortic Valve Replacement

## Interventions

- **DRUG:** Vitamin K antagonist or direct oral anticoagulant treatment
- **DRUG:** Aspirin

## Key facts

- **NCT ID:** NCT02735902
- **Lead sponsor:** Centre Hospitalier Universitaire de Nīmes
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-01
- **Primary completion:** 2023-02-02
- **Final completion:** 2024-01-19
- **Target enrollment:** 170 (ACTUAL)
- **Last updated:** 2024-07-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02735902

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02735902, "Anticoagulation Alone Versus Anticoagulation and Aspirin Following Transcatheter Aortic Valve Interventions (1:1)". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT02735902. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*